(CRI) Creotech Instruments S.A. - Ratings and Ratios

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock •

CRI: Aircraft, Spacecraft, Satellites, Computers, Navigation, Control, Data

Creotech Instruments S.A. (WAR:CRI) is a Poland-based company specializing in advanced technologies for the space, science, and defense sectors. Established in 2008 and headquartered in Piaseczno, the company has built a diverse portfolio that includes the production of aircraft and spacecraft components, electronic systems, telecommunications equipment, and precision measurement instruments. Creotech also engages in the generation and distribution of electricity and manufactures control and navigation apparatuses. The company’s expertise extends to specialized software development, engineering consultancy, and technical design services.

Creotech offers innovative solutions such as the GeomaticRemoteEye (GREy) platform, which provides advanced data visualization and analysis for topography, obstacles, and airspace. Additionally, the company operates CreoDIAS, a satellite data repository, and manages geoportals for spatial data applications. These technologies are integral to industries requiring precise geospatial intelligence, such as urban planning, environmental monitoring, and telecommunications infrastructure development.

As a key player in Poland’s aerospace and defense industry, Creotech Instruments S.A. has established itself through its commitment to R&D and innovation. The company’s products and services are not only utilized domestically but are also exported internationally, reflecting its growing global presence.

From a financial perspective, Creotech Instruments S.A. is valued at a market capitalization of 459.21M PLN. The company’s price-to-book (P/B) ratio stands at 5.98, indicating a premium valuation relative to its book value. However, the return on equity (RoE) is reported at -25.47, suggesting current profitability challenges. The forward P/E ratio is 0.00, indicating limited visibility into future earnings growth.

From a technical analysis standpoint, the stock is currently trading at 190.50 PLN, slightly above its 20-day simple moving average (SMA) of 189.77. The 50-day SMA is 180.53, and the 200-day SMA is 177.83, indicating a bullish trend over the medium term. The Average True Range (ATR) of 8.21 reflects moderate volatility.

Looking ahead, over the next three months, the stock is expected to trade within a range of 178.00 to 203.00 PLN. The immediate support level is at 177.83 (SMA 200), while the resistance level is at 203.00, based on historical price action. The relatively high P/S ratio of 13.58 suggests that the market expects strong revenue growth, which could drive the stock higher if realized.

Additional Sources for CRI Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CRI Stock Overview

Market Cap in USD 135m
Sector Industrials
Industry Aerospace & Defense
GiC Sub-Industry Aerospace & Defense
IPO / Inception

CRI Stock Ratings

Growth Rating 51.6
Fundamental -47.6
Dividend Rating 0.0
Rel. Strength 9.71
Analysts -
Fair Price Momentum 260.73 PLN
Fair Price DCF -

CRI Dividends

No Dividends Paid

CRI Growth Ratios

Growth Correlation 3m 88.2%
Growth Correlation 12m 3.9%
Growth Correlation 5y 63.1%
CAGR 5y 40.98%
CAGR/Max DD 5y 0.86
Sharpe Ratio 12m -0.08
Alpha 32.29
Beta -0.027
Volatility 47.50%
Current Volume 22.2k
Average Volume 20d 4.3k
What is the price of CRI stocks?
As of April 16, 2025, the stock is trading at PLN 245.50 with a total of 22,196 shares traded.
Over the past week, the price has changed by +12.10%, over one month by +17.46%, over three months by +31.28% and over the past year by +36.39%.
Is Creotech Instruments S.A. a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Creotech Instruments S.A. (WAR:CRI) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -47.56 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRI as of April 2025 is 260.73. This means that CRI is currently overvalued and has a potential downside of 6.2%.
Is CRI a buy, sell or hold?
Creotech Instruments S.A. has no consensus analysts rating.
What are the forecast for CRI stock price target?
According to ValueRays Forecast Model, CRI Creotech Instruments S.A. will be worth about 281.6 in April 2026. The stock is currently trading at 245.50. This means that the stock has a potential upside of +14.7%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 281.6 14.7%